10-114187895-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001395205.1(TDRD1):āc.64A>Gā(p.Met22Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,610,658 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001395205.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TDRD1 | NM_001395205.1 | c.64A>G | p.Met22Val | missense_variant | 2/25 | ENST00000695399.1 | NP_001382134.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TDRD1 | ENST00000695399.1 | c.64A>G | p.Met22Val | missense_variant | 2/25 | NM_001395205.1 | ENSP00000511878.1 | |||
TDRD1 | ENST00000251864.7 | c.64A>G | p.Met22Val | missense_variant | 2/26 | 1 | ENSP00000251864.2 | |||
TDRD1 | ENST00000369282.5 | c.64A>G | p.Met22Val | missense_variant | 2/25 | 5 | ENSP00000358288.1 | |||
TDRD1 | ENST00000369280.1 | c.64A>G | p.Met22Val | missense_variant | 2/24 | 5 | ENSP00000358286.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000805 AC: 2AN: 248378Hom.: 0 AF XY: 0.00000744 AC XY: 1AN XY: 134398
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1458436Hom.: 0 Cov.: 31 AF XY: 0.00000276 AC XY: 2AN XY: 725680
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74386
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 08, 2024 | The c.64A>G (p.M22V) alteration is located in exon 2 (coding exon 1) of the TDRD1 gene. This alteration results from a A to G substitution at nucleotide position 64, causing the methionine (M) at amino acid position 22 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at